Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 6.25
0.00 (0.00%)
Aug 15, 2025, 5:27 PM GMT+1
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 23.50 million as of August 15, 2025. Its market cap has decreased by -33.54% in one year.
Market Cap
23.50M
Enterprise Value
20.83M
Revenue
6.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.25
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 23.50M, a decrease of -76.73%. That is a compound annual growth rate of -26.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 23.50M | -21.28% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | 90.44M | -10.43% |
| Dec 15, 2020 | 100.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.76B |
| GSK plc | 57.11B |
| Haleon | 31.97B |
| Smith & Nephew | 11.74B |
| ConvaTec Group | 4.66B |
| Hikma Pharmaceuticals | 3.97B |
| HUTCHMED (China) | 2.09B |
| Oxford Nanopore Technologies | 2.02B |